Unusual Clinical Course in a Case with Relapsing Polychondritis Showing Hypertrophic Pachymeningitis Complicated by a

Ken Yasuda1, Takakuni Maki1, Kohei Nishimura1

  • 1Department of Neurology, Graduate School of Medicine, Kyoto University, Japan.

PubMed

Insights

This case report describes hypertrophic pachymeningitis (HP) in a relapsing polychondritis (RP) patient with a Klebsiella pneumoniae infection. Prompt diagnosis and treatment led to symptom resolution, emphasizing infection

Area of Science:

  • Neurology
  • Rheumatology
  • Infectious Diseases

Background:

  • Relapsing polychondritis (RP) is a rare autoimmune disorder.
  • Central nervous system involvement in RP is uncommon but possible.
  • Hypertrophic pachymeningitis (HP) is a rare manifestation.

Purpose of the Study:

  • To report the first case of HP in an RP patient with a concurrent Klebsiella pneumoniae infection.
  • To highlight the diagnostic and therapeutic considerations for this rare presentation.

Main Methods:

  • Case presentation of a 48-year-old male with neurological symptoms.
  • Brain MRI to evaluate pachymeningitis.
  • Dural biopsy for microbial identification.
  • Auricular cartilage biopsy for RP diagnosis.
  • Treatment with corticosteroids and infliximab.

Main Results:

  • The patient presented with transient neurological deficits.
  • Brain MRI revealed diffuse pachymeningitis.
  • Klebsiella pneumoniae was identified from a dural biopsy.
  • RP was confirmed via auricular cartilage biopsy.
  • Symptoms resolved following treatment.

Conclusions:

  • This case underscores the importance of considering bacterial infections in patients with RP and HP.
  • Concurrent Klebsiella pneumoniae infection can mimic or exacerbate HP in RP.
  • Integrated management of autoimmune disease and infection is crucial for favorable outcomes.

Related Concept Videos

Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
175
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
116
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
173
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
263
Pleural Effusion II: Symptoms and Management01:28

Pleural Effusion II: Symptoms and Management

Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
133
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
257